Article
HIV Drug to Aid Melanoma Therapies?
Cancer cell - 14 Mar 2016
Kim Hyungsoo, Ronai Ze'ev A
Abstract excerpt
The HIV1 protease inhibitor nelfinavir is being investigated as a cancer therapeutic. In this issue of Cancer Cell, Smith et al. (2016) report that nelfinavir suppresses MITF expression induced by MAPK pathway inhibition in melanoma cells and sensitizes melanoma cells with NRAS or BRAF plus NRAS mutations to MEK inhibitors.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
